TY  - GEN
AU  - Jarskog,L Fredrik
AU  - Lowy,Martin T
AU  - Grove,Richard A
AU  - Keefe,Richard S E
AU  - Horrigan,Joseph P
AU  - Ball,M Patricia
AU  - Breier,Alan
AU  - Buchanan,Robert W
AU  - Carter,Cameron S
AU  - Csernansky,John G
AU  - Goff,Donald C
AU  - Green,Michael F
AU  - Kantrowitz,Joshua T
AU  - Keshavan,Matcheri S
AU  - Laurelle,Marc
AU  - Lieberman,Jeffrey A
AU  - Marder,Stephen R
AU  - Maruff,Paul
AU  - McMahon,Robert P
AU  - Seidman,Larry J
AU  - Peykamian,Margaret A
TI  - A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
SN  - 1573-2509
PY  - 2016///0323
KW  - Adult
KW  - Antipsychotic Agents
KW  - therapeutic use
KW  - Benzazepines
KW  - Cognition Disorders
KW  - drug therapy
KW  - Female
KW  - Histamine Antagonists
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neuropsychological Tests
KW  - Psychiatric Status Rating Scales
KW  - Schizophrenia
KW  - complications
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.schres.2015.01.041
ER  -